Neonatal alloimmune thrombocytopenia epidemiology and demographics
|
Neonatal alloimmune thrombocytopenia Microchapters |
|
Differentiating Neonatal alloimmune thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Neonatal alloimmune thrombocytopenia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Neonatal alloimmune thrombocytopenia epidemiology and demographics |
|
FDA on Neonatal alloimmune thrombocytopenia epidemiology and demographics |
|
on Neonatal alloimmune thrombocytopenia epidemiology and demographics |
|
Neonatal alloimmune thrombocytopenia epidemiology and demographics in the news |
|
Blogs on Neonatal alloimmune thrombocytopenia epidemiology and demographics |
|
Directions to Hospitals Treating Neonatal alloimmune thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
NAIT occurs in somewhere between 1/800 [1] and 1/5000 [2] live births (more recent studies of NAIT seem to indicate that it occurs in somewhere between 1/800 and 1/1000 live births).
References
- ↑ Doctor Cecil Kaplan (2003-11-01). "Fetal and Neonatal Alloimmune Thrombocytopenia" (PDF). Orphanet Encyclopedia. Retrieved 2007-09-23.
- ↑ Janice G. McFarland, Richard H. Aster, James E. Bussel, John G. Gianopoulos, Rebecca S. Derbes, and Peter J. Newman (1991-11-01). "Prenatal Diagnosis of Neonatal Alloimmune Thrombocytopenia Using Allele-Specific Oligonucleotide Probes". Blood Journal. Retrieved 2007-09-23.